Melissa Benavente


Postgraduate Research Student

About

My research project

Publications

Maarten W. Taal, Bethany Lucas, Paul Roderick, Paul Cockwell, David C. Wheeler, Moin A. Saleem, Simon D. S. Fraser, Rosamonde E. Banks, Tim Johnson, Lorna J. Hale, Uwe Andag, Philipp Skroblin, Michaela Bayerlova, Robert Unwin, Nicolas Vuilleumier, Rodolphe Dusaulcy, Fiona Robertson, Elizabeth Colby, David Pitcher, Fiona Braddon, Melissa Benavente, Elaine Davies, Michael Nation, Philip A. Kalra (2023)Associations with age and glomerular filtration rate in a referred population with chronic kidney disease: methods and baseline data from a UK multicentre cohort study (NURTuRE-CKD), In: Nephrology, dialysis, transplantation38(11)2617pp. 2617-2626 Oxford Univ Press

Background Chronic kidney disease (CKD) is common but heterogenous and is associated with multiple adverse outcomes. The National Unified Renal Translational Research Enterprise (NURTuRE)-CKD cohort was established to investigate risk factors for clinically important outcomes in persons with CKD referred to secondary care. Methods Eligible participants with CKD stages G3-4 or stages G1-2 plus albuminuria >30 mg/mmol were enrolled from 16 nephrology centres in England, Scotland and Wales from 2017 to 2019. Baseline assessment included demographic data, routine laboratory data and research samples. Clinical outcomes are being collected over 15 years by the UK Renal Registry using established data linkage. Baseline data are presented with subgroup analysis by age, sex and estimated glomerular filtration rate (eGFR). Results A total of 2996 participants was enrolled. Median (interquartile range) age was 66 (54-74) years, eGFR 33.8 (24.0-46.6) mL/min/1.73 m(2) and urine albumin to creatinine ratio 209 (33-926) mg/g; 58.5% were male. Of these participants, 1883 (69.1%) were in high-risk CKD categories. Primary renal diagnosis was CKD of unknown cause in 32.3%, glomerular disease in 23.4% and diabetic kidney disease in 11.5%. Older participants and those with lower eGFR had higher systolic blood pressure and were less likely to be treated with renin-angiotensin system inhibitors (RASi) but were more likely to receive a statin. Female participants were less likely to receive a RASi or statin. Conclusions NURTuRE-CKD is a prospective cohort of persons who are at relatively high risk of adverse outcomes. Long-term follow-up and a large biorepository create opportunities for research to improve risk prediction and to investigate underlying mechanisms to inform new treatment development.

Elizabeth Colby, Samantha Hayward, Melissa Benavente, Fiona Robertson, Agnieszka Bierzynska, Amy Osborne, Kevon Parmesar, Maryam Afzal, Tracey Chapman, Fatima Ullah, Elaine Davies, Michael Nation, Wendy Cook, Tim Johnson, Uwe Andag, Olivier Radresa, Philipp Skroblin, Michaela Bayerlova, Robert Unwin, Nicolas Vuilleumier, Rosamonde E Banks, Fiona Braddon, Ania Koziell, Maarten W Taal, Gavin I Welsh, Moin A Saleem (2024)National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study, In: Clinical kidney journal17(8)096 Oxford University Press

Graphical Abstract

Thomas Phillips, Scott Harris, Olalekan Lee Aiyegbusi, Bethany Lucas, Melissa Benavente, Paul J. Roderick, Paul Cockwell, Philip A. Kalra, David C. Wheeler, Maarten W. Taal, Simon D. S. Fraser (2024)Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohort, In: Clinical kidney journal17(2)010pp. sfae010-sfae010 Oxford Univ Press

Background. Many non-modifiable factors are associated with poorer health-related quality of life (HRQoL) experienced by people with chronic kidney disease (CKD). We hypothesize that potentially modifiable factors for poor HRQoL can be identified among CKD patients, providing potential targets for intervention. Method. The National Unified Renal Translational Research Enterprise Chronic Kidney Disease (NURTuRE-CKD) cohort study recruited 2996 participants from nephrology centres with all stages of non-dialysis-dependent CKD. Baseline data collection for sociodemographic, anthropometric, biochemical and clinical information, including Integrated Palliative care Outcome Scale renal, Hospital Anxiety and Depression score (HADS) and the 5-level EuroQol-5D (EQ-5D-5L) as HRQoL measure, took place between 2017 and 2019. EQ-5D-5L dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) were mapped to an EQ-5D-3L value set to derive index value. Multivariable mixed effects regression models, adjusted for known factors affecting HRQoL with recruitment region as a random effect, were fit to assess potentially modifiable factors associated with index value (linear) and within each dimension (logistic). Results. Among the 2958/2996 (98.7%) participants with complete EQ-5D data, 2201 (74.4%) reported problems in at least one EQ-5D-5L dimension. Multivariable linear regression identified independent associations between poorer HRQoL (EQ-5D-3L index value) and obesity (body mass index >= 30.0 kg/m2, beta -0.037, 95% CI -0.058 to -0.016, P = .001), HADS depression score >= 8 (beta -0.159, -0.182 to -0.137, P < .001), anxiety score >= 8 (beta -0.090, -0.110 to -0.069, P < .001), taking >= 10 medications (beta -0.065, -0.085 to -0.046, P < .001), sarcopenia (beta -0.062, -0.080 to -0.043, P < .001) haemoglobin